Mark Flanigan
Family Medicine · Denver, CONPI 1457344624
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 198 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,592 and has fallen 96.6% since, to $55 in 2022. Among family medicine clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 198 payments — averaging $15.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$549
- AstraZeneca$385
- Novo Nordisk$294
- Lilly USA, LLC$242
- GSK$165
- Boehringer Ingelheim$152
- plus $1K from 29 others
What the payments were for
- Food & beverage$3,144100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 37 | $549 |
| AstraZeneca | 27 | $385 |
| Novo Nordisk | 16 | $294 |
| Lilly USA, LLC | 19 | $242 |
| GSK | 11 | $165 |
| Boehringer Ingelheim | 8 | $152 |
| Merck | 10 | $141 |
| Amgen | 6 | $137 |
| Pfizer | 9 | $131 |
| Amarin Pharma, Inc. | 7 | $127 |
| Eisai Inc. | 5 | $76 |
| Johnson & Johnson | 4 | $66 |
| Astellas Pharma US Inc | 4 | $63 |
| Genentech USA, Inc. | 3 | $62 |
| Adlon Therapeutics L.p. | 3 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Sanofi-aventis U.S. LLC | 3 | $41 |
| Grifols USA, LLC | 2 | $40 |
| Cranial Technologies, Inc | 2 | $37 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Bayer | 2 | $34 |
| Nestle Healthcare Nutrition Inc. | 1 | $25 |
| Abbott | 1 | $25 |
| Hologic Sales And Service, LLC | 2 | $21 |
| Ironshore Pharmaceuticals Inc. | 1 | $21 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Therapeuticsmd, Inc. | 1 | $20 |
| IBSA Pharma Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Optinose US, Inc. | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $12 |
How this compares
$3,144 in reported general payments places this provider in the 90th percentile of 2,079 family medicine providers in Colorado.
Other family medicine in Denver
- Ethan LazarusDenver$688K
- Mark DeutchmanDenver$258K
- Mia ScottDenver$53K
- Flory KreutterDenver$13K
- Khoi NguyenDenver$13K
- Michael de NardisLarkspur$335K
- Matthew YoungColorado Springs$270K
- Kari UusinarkausWoodland Park$254K
- Michael MeekerUsaf Academy$174K
- Carolynn Francavilla BrownLakewood$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.